CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 86 filers reported holding CUREVAC N V in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $882,448 | +51.3% | 84,688 | +1.2% | 0.00% | – |
| Q1 2023 | $583,347 | +14.0% | 83,694 | -1.4% | 0.00% | – |
| Q4 2022 | $511,706 | -24.6% | 84,860 | -1.5% | 0.00% | – |
| Q3 2022 | $679,000 | -69.3% | 86,164 | -23.6% | 0.00% | – |
| Q1 2022 | $2,212,000 | -39.8% | 112,749 | +5.2% | 0.00% | -100.0% |
| Q4 2021 | $3,677,000 | -38.2% | 107,161 | -1.7% | 0.00% | 0.0% |
| Q3 2021 | $5,953,000 | -44.1% | 108,993 | -24.8% | 0.00% | -50.0% |
| Q2 2021 | $10,656,000 | – | 145,014 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $286,707,000 | 46.92% |
| Ally Bridge Group (NY) LLC | 110,000 | $10,061,000 | 1.93% |
| Parametrica Management Ltd | 44,695 | $3,968,000 | 1.91% |
| Renaissance Capital LLC | 123,983 | $11,339,000 | 1.68% |
| Samsara BioCapital, LLC | 95,318 | $8,718,000 | 1.61% |
| Ikarian Capital, LLC | 360,000 | $32,925,000 | 1.11% |
| SECTOR GAMMA AS | 25,000 | $2,287,000 | 0.42% |
| Fosun International Ltd | 50,000 | $4,438,000 | 0.35% |
| Ikarian Capital, LLC | 100,000 | $9,145,000 | 0.31% |
| Baillie Gifford | 5,830,101 | $533,221,000 | 0.30% |